The Hereditary Neurological Disease Centre (HNDC) is a 501(c)(3) tax-exempt organization based in Wichita, KS. Their mission is to provide diagnosis, disease management, and support services for individuals with Huntington Disease and other hereditary neurological diseases, offering diagnostic services, professional care, genetic testing, patient advocacy, and serving as a genetic testing, study group, and research site facility.
HNDC is actively involved in research and clinical trials, with recent participation in a Phase 3 trial of Valbenazine and the development of the investigational medicine RG6042 for Huntington's disease. Their dedication to advancing treatment options and providing hope for individuals and families affected by hereditary neurological diseases is evident in their ongoing efforts and collaborations with patient groups, medical professionals, and health authorities worldwide.
Generated from the website